![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
MICHEAL LEWIS, Chairman & CEO Rainer Technology, GLYN EDWARDS, Interim CEO BioIndustry Association, CHRISTOPHER COE, Managing Partner European Life Science Practice CTPartners
Thursday 10 May 2012, 18:30-20:30
MERGERS & ACQUISITIONS in the industry Is There Life After the Financial Crash or Do We Need a Defibrillator?
- 👤 Speaker: MICHEAL LEWIS, Chairman & CEO Rainer Technology, GLYN EDWARDS, Interim CEO BioIndustry Association, CHRISTOPHER COE, Managing Partner European Life Science Practice CTPartners
- 📅 Date & Time: Thursday 10 May 2012, 18:30 - 20:30
- 📍 Venue: LT1, Judge Business School, University of Cambridge
Questions? Contact
Lalarukh Haris
Abstract
PANEL DISCUSSION & INSIGHT into the Biotech Industry:
MICHEAL LEWIS , Chairman & CEO Rainer Technology ‘M&A in Medtech, Diagnostics, Biotech, Dental & Pharma, what are the differences?’
GLYN EDWARDS , Interim CEO BioIndustry Association ‘Biotech, boom time or doom time for M&A?’
CHRISTOPHER COE , Managing Partner European Life Science Practice CTPartners ‘The corporate view of M&A, the inside-out view of M&A targets’
SIGN UP HERE : http://mandaseries.eventbrite.com/
Series This talk is part of the Oxbridge Biotech Roundtable series.
Included in Lists
Note: Ex-directory lists are not shown.